Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 5, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 30
- +2 vs. Q3 2023
- Portfolio value
- $412.1M
- +$20.9M (+5.3%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MDTMedtronic plc | Stock | 435,075 | $35.8M | 8.7% | +107,172+32.7% | Added | History |
| PFEPfizer Inc | Stock | 1,093,416 | $31.5M | 7.6% | +1,093,416 | New | History |
| GILDGilead Sciences, Inc. | Stock | 382,362 | $31.0M | 7.5% | −240,761−38.6% | Reduced | History |
| BIIBBiogen Inc. | COM | 102,234 | $26.5M | 6.4% | −2,052−2.0% | Reduced | History |
| INCYIncyte Corp | COM | 398,699 | $25.0M | 6.1% | −33,846−7.8% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 374,687 | $19.2M | 4.7% | −297,093−44.2% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 247,531 | $19.1M | 4.6% | +17,942+7.8% | Added | History |
| CVSCVS Health Corp | Stock | 219,000 | $17.3M | 4.2% | +219,000 | New | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 141,218 | $17.2M | 4.2% | −17,851−11.2% | Reduced | History |
| CAHCardinal Health Inc | Stock | 164,305 | $16.6M | 4.0% | −99,831−37.8% | Reduced | History |
| CNCCentene Corp | Stock | 216,416 | $16.1M | 3.9% | −6,732−3.0% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 193,279 | $14.6M | 3.5% | +35,304+22.3% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 187,556 | $14.3M | 3.5% | −25,439−11.9% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 27,807 | $13.1M | 3.2% | −13,340−32.4% | Reduced | History |
| BAXBaxter International Inc | Stock | 328,132 | $12.7M | 3.1% | +134,889+69.8% | Added | History |
| GMEDGlobus Medical Inc | Stock | 234,374 | $12.5M | 3.0% | +12,547+5.7% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 50,686 | $11.5M | 2.8% | −14,171−21.8% | Reduced | History |
| BRKRBruker Corp | COM | 127,312 | $9.35M | 2.3% | +23,957+23.2% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 86,247 | $8.32M | 2.0% | −9,801−10.2% | Reduced | History |
| QGENQiagen N.V. | SHS NEW | 190,539 | $8.28M | 2.0% | +89,826+89.2% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 23,609 | $7.62M | 1.8% | +23,609 | New | History |
| IONSIonis Pharmaceuticals Inc | COM | 145,012 | $7.34M | 1.8% | −20,604−12.4% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 32,092 | $6.14M | 1.5% | −20,876−39.4% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 188,111 | $5.89M | 1.4% | +8,326+4.6% | Added | History |
| ILMNIllumina, Inc. | COM | 40,592 | $5.65M | 1.4% | +40,592 | New | History |
| ALKSAlkermes plc. | SHS | 200,000 | $5.55M | 1.3% | +200,000 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 102,490 | $4.90M | 1.2% | −12,676−11.0% | Reduced | History |
| ABTAbbott Laboratories | Stock | 39,876 | $4.39M | 1.1% | +39,876 | New | History |
| LNTHLantheus Holdings, Inc. | Stock | 52,316 | $3.24M | 0.8% | +1,354+2.7% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 148,538 | $1.49M | 0.4% | 00.0% | Unchanged | History |
Sold out since Q3 2023 (4)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| BDXBecton Dickinson & Co | Stock | 71,884 | $18.6M | 4.7% | History |
| CTLTCatalent, Inc. | COM | 207,129 | $9.43M | 2.4% | History |
| KVUEKenvue Inc. | Stock | 144,017 | $2.89M | 0.7% | History |
| AMEDAmedisys Inc | COM | 24,585 | $2.30M | 0.6% | History |